This study is in progress, not accepting new patients
A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer
Summary
- Eligibility
- for people ages 18-130 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Rahul Aggarwal
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Rahul Aggarwal
I am a Medical Oncologist within the Division of Hematology/Oncology at the University of California San Francisco. My clinical practice focuses on patients with advanced solid tumor malignancies with a particular emphasis on genitourinary malignancies including prostate, kidney, bladder, and testicular cancer.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AstraZeneca
- Links
- CSP_redacted CSR Synopsis_redacted SAP_redacted
- ID
- NCT04564027
- Phase
- Phase 2 Solid Tumor Research Study
- Study Type
- Interventional
- Participants
- About 54 people participating
- Last Updated